NEWS TIPS & FEATURES

Neratinib Improves Cancer-Free Survival in Early Breast Cancer

The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast... [...]


Cabozantinib Does Not Demonstrate Improvements in Advanced Prostate Cancer

In a recent study, the targeted agent cabozantinib did not demonstrate an improvement in outcomes compared to prednisone, among men with advanced prostate cancer. These results were recently published... [...]


3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma

Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... [...]


Amy Gibson Creates FIRST Cancer HairCARE Center for CancerConnect.com

Amy Gibson Author | Emmy Nominated Soap Opera Star | Cancer Hair Loss Expert Leading Hair Loss Consultant Amy Gibson breaks new ground again, creating the Cancer HairCARE Center by Amy Gibson premiering... [...]


Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration... [...]


Summer Camp Support Network for Children Affected by a Parent’s Cancer

Camp Kesem at Syracuse University is a free, week-long summer camp for children affected by a parent’s cancer. Over 3 million children live with a parent with cancer, many more have lost a parent to... [...]


FDA Places Hold on a Trial Evaluating Genetically Engineered Immune Cells for Cancer Treatment

The United States Food and Drug Administration (FDA) has placed a hold on a clinical trial, referred to as the ROCKET trial, due to side effects of the treatment that may be associated with 3 patient deaths. Chimeric... [...]


Study Suggests Men with Metastatic Prostate Cancer Should Be Tested for Inherited Mutations

Ever since inherited mutations in BRCA genes were first linked to breast and ovarian cancer two decades ago, this information has been used as a way to help empower women. Those who have the mutations... [...]


Niraparib Improves Progression-Free Survival in Ovarian Cancer

The PARP inhibitor niraparib improves the time to cancer progression among patients with recurrent ovarian cancer when used as maintenance therapy during platinum-based chemotherapy. Each year in the United... [...]


« More News Tips & Features

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS